Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
CLINSQUARE: CLINICAL RESEARCH COURSES
Saturday, May 17, 2025
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Facebook
Twitter
CLINSQUARE: Clinical Rsearch Courses by LIFEPRONOW
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
Home
Latest Pharma-News
Latest Pharma-News
Latest Pharma-News
J&J announced Icotrokinra results show 75% of adolescents with plaque psoriasis achieved completely clear skin
admin
-
April 11, 2025
Latest Pharma-News
Sanofi’s Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis
admin
-
April 9, 2025
Latest Pharma-News
Novartis receives FDA accelerated approval for Vanrafia for proteinuria reduction in primary IgA nephropathy
admin
-
April 9, 2025
Latest Pharma-News
AstraZeneca showcases innovation in infectious disease protection at ESCMID Global 2025
admin
-
April 9, 2025
Latest Pharma-News
FDA Alerts Patients of Potential to Miss Critical Safety Alerts Due to Phone Settings When Using Smartphone-Compatible Diabetes Devices
admin
-
February 10, 2025
Latest Pharma-News
Epsilogen licences MOv18 IgE, an anti-folate receptor alpha IgE antibody from King’s College London
admin
-
April 21, 2020
0
Latest Pharma-News
WHO guidance helps detect iron deficiency and protect brain development
admin
-
April 21, 2020
0
Latest Pharma-News
Sanofi to present Phase 2 detailed results of its brain-penetrant BTK inhibitor in relapsing multiple sclerosis
admin
-
April 21, 2020
0
Latest Pharma-News
Novartis to study hydroxychloroquine for Covid-19
admin
-
April 21, 2020
0
Latest Pharma-News
New research to assess extent of coronavirus infection in children and teenagers
admin
-
April 21, 2020
0
Latest Pharma-News
Oxford project receives funding to assess novel coronavirus infection rates in children and teenagers across the UK.
admin
-
April 21, 2020
0
Latest Pharma-News
NIH to launch public-private partnership to speed COVID-19 vaccine and treatment options
admin
-
April 21, 2020
0
Latest Pharma-News
EMA review of Picato concludes medicine’s risks outweigh its benefits
admin
-
April 20, 2020
0
Latest Pharma-News
COVID-19 therapy, vaccine, epidemiology and policy development research boosted by twenty-one new projects
admin
-
April 20, 2020
0
Latest Pharma-News
FDA Approves First New Drug Under International Collaboration, A Treatment Option for Patients with HER2-Positive Metastatic Breast Cancer
admin
-
April 18, 2020
0
Latest Pharma-News
FDA Approves First Targeted Treatment for Patients with Cholangiocarcinoma, a Cancer of Bile Ducts
admin
-
April 18, 2020
0
Latest Pharma-News
Miami-Dade Transit Workers File Lawsuit, Allege ‘Life-Threatening’ Violations During Pandemic
admin
-
April 18, 2020
0
1
...
121
122
123
...
145
Page 122 of 145
- Advertisment -
Most Read
J&J announced Icotrokinra results show 75% of adolescents with plaque psoriasis achieved completely clear skin
April 11, 2025
Sanofi’s Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis
April 9, 2025
Novartis receives FDA accelerated approval for Vanrafia for proteinuria reduction in primary IgA nephropathy
April 9, 2025
AstraZeneca showcases innovation in infectious disease protection at ESCMID Global 2025
April 9, 2025